YNIOS Pharma

La Hulpe ·KBO/BCE: BE 0783.494.239

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	72.4%	3.8%	better than 85% of 52 sector peers
Net result	€342k	€-6k	better than 95% of 52 sector peers
Equity	€702k	€2k	better than 95% of 52 sector peers
Gross operating margin	€393k	€-2k	better than 95% of 52 sector peers
Total assets	€970k	€87k	better than 95% of 52 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€970k
Fixed assets	21/28	€704k
Intangible fixed assets	21	€704k
Current assets	29/58	€266k
Amounts receivable within one year	40/41	€9k
Cash & bank	54/58	€257k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€970k
Equity	10/15	€702k
Contributions / capital	10/11	€692k
Accumulated profits (losses)	14	€11k
Amounts payable	17/49	€268k
Amounts payable within one year	42/48	€268k
Trade debts payable within one year	44	€7k
Income statement
Gross operating margin	9900	€393k
Operating result	9901	€343k
Financial income	75	€236
Financial charges	65	€1k
Result before taxes	9903	€342k
Net result for the period	9904	€342k
Result to be appropriated	9905	€342k

Summary